First Trust Nasdaq Pharmaceuticals ETF (FTXH)

First Trust Nasdaq Pharmaceuticals ETF is trading at $44.24, up 1.07% on the session. The 50 day average sits at $41.68 and the 200 day at $37.19, which puts the stock in a uptrend. RSI is at 70.7, which reads as overbought, and MACD is bullish crossover. Volume is below average.

The nearest support is around $40.86 with resistance near $44.78, so that band frames the current range. Average daily movement is roughly $0.74, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 80 out of 100 combines a trend score of 97, momentum of 73 and a risk score of 62.

The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.